← Back to Search

Experimental for Coronavirus

N/A

Waitlist Available

Led By Carl Latkin, PhD

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month

Awards & highlights

Study Summary

This trial studies the public's views and access to COVID-19 vaccines, plus any barriers to getting vaccinated, among people who use drugs.

Who is the study for?

This trial is for people who have used opioids in the last two weeks. It's focused on understanding their views on COVID-19 vaccines, access to these vaccines, and what might be stopping them from getting vaccinated. There are no specific exclusion criteria listed.Check my eligibility

What is being tested?

The study isn't testing a new drug or treatment. Instead, it's analyzing how people who inject drugs feel about COVID-19 vaccines and identifying any obstacles they face in getting vaccinated.See study design

What are the potential side effects?

Since this trial does not involve a medical intervention or drug being tested, there are no side effects associated with the study itself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Vaccine acceptance as assessed by the Oxford COVID-19 Vaccine Hesitancy Scale

Trial Design

1Treatment groups

Experimental Treatment

Group I: ExperimentalExperimental Treatment1 Intervention

behavioral intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor

410 Previous Clinical Trials

2,116,890 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,499 Total Patients Enrolled

Carl Latkin, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health

5 Previous Clinical Trials

4,287 Total Patients Enrolled

Media Library

Experimental Clinical Trial Eligibility Overview. Trial Name: NCT05769023 — N/A

Coronavirus Research Study Groups: Experimental

Coronavirus Clinical Trial 2023: Experimental Highlights & Side Effects. Trial Name: NCT05769023 — N/A

Experimental 2023 Treatment Timeline for Medical Study. Trial Name: NCT05769023 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for individuals willing to enroll in this clinical trial?

"Per the clinicaltrials.gov platform, this experiment is not currently taking on new participants. The trial was initially posted on January 1st 2023 and its most recent update occurred on March 13th 2023. At present, there are 840 different trials recruiting patients in lieu of this one."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Spatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs

2023. "A Spatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05769023.